The Cornea and Laser Eye Institute - Hersh Vision Group is one of the premier LASIK laser vision correction and corneal disease subspecialty practices in the United States, and the CLEI Center for Keratoconus is nationally respected for research and management of keratoconus. Hersh, Greenstein, Gelles, Chu and our exceptional team give our patients the four elements most important in choosing a sp
ecialist - the best education and training, unsurpassed depth and breadth of experience, the most advanced technology, and focused dedication to the field... This is all we do. Hersh in 1995, the Cornea and Laser Eye Institute is dedicated to clinical care and research in LASIK and corneal surgery. Having played a central role in the original FDA-approval LASIK laser study now over 20 years ago, today we are pleased to continue offering our patients the best in vision correction surgery and other state-of-the-art eye surgery procedures. The all-laser LASIK technique, performed at our state-of-the-art laser center in New Jersey, is our preferred laser vision correction treatment in patients with nearsightedness, farsightedness, or astigmatism. Dr. Hersh was the lead author of the clinical trial that led to first FDA approval of the excimer laser for vision correction surgery in 1995. He has the longest and most extensive experience in LASIK in the U.S. Dr. Steven Greenstein, trained under Dr. Hersh and is an expert in all forms of cornea and refractive surgery, performing LASIK, PRK, ICL, cataract and corneal transplant procedures. Dr. Chu specializes in corneal diseases and surgery and is nationally recognized for his expertise in inflammatory and immunologic conditions, including corneal wound healing, surgical and non-surgical therapies of various ocular inflammatory diseases, patients with cornea problems and difficult to treat immunologic ocular conditions, including uveitis, scleritis and ocular pemphigoid. Dr. Gelles is nationally recognized for his expertise in specialty contact lenses for visual rehabilitation in corneal disease and therapeutic treatment of ocular surface disease. The CLEI Center of Keratoconus was founded in 2002 by Dr. Peter Hersh as a subspecialty center devoted to all aspects of keratoconus care. The Center provides keratoconus patients with state-of-the art keratoconus diagnosis, therapeutic care, subspecialty contact lens care, and the complete range of surgical treatments. Dr. Greenstein and Hersh are dedicated to surgical innovation, from crosslinking, Intacs and Topography Guided PRK to laser assisted corneal transplantation. Dr. Gelles' clinical work is dedicated exclusively to specialty contact lenses with a primary focus on keratoconus and is at the forefront of lens design development, scan and impression based lens design and higher order aberration correcting optics. At CLEI, keratoconus patients candidates undergo a comprehensive and lengthy evaluation using all the newest state-of-the-art technologies. Using this evaluation, your individual needs can be matched to the proper treatment – our goal to optimize results and achieve improved, long term, stable vision. In addition to clinical care, Drs. Hersh, Greenstein, and Gelles are at the forefront of research and innovation in keratoconus treatment. Dr. Hersh and Greenstein wrote the seminal papers on corneal collagen crosslinking in the United States and have written multiple book chapters on the subject. Dr. Hersh was the medical monitor and lead author of the study leading to FDA approval of corneal crosslinking for keratoconus. The Cornea and Laser Eye Institute and CLEI Center for Keratoconus are located in Teaneck, New Jersey, an easy commute from Paramus, Morristown, and Princeton, New Jersey, and is a popular LASIK destination for LASIK NJ patients in Manhattan, New York City, Connecticut, and Pennsylvania. About the doctors:
Peter S. graduated from Princeton University and received his M.D. from Johns Hopkins Medical School. He completed his ophthalmology residency at Harvard Medical School where afterwards he received specialized fellowship training in corneal surgery. Dr. Hersh remained on the full-time faculty at Harvard for several years. In 1995, he founded the Cornea and Laser Eye Institute – Hersh Vision Group in New Jersey, dedicated to clinical care and research in LASIK and corneal surgery. He founded the CLEI Center for Keratoconus in 2002, a subspecialty center focused on treatment and research in keratoconus. In addition to directing the Cornea and Laser Eye Institute, Dr. Hersh is Clinical Professor of Ophthalmology and Director of the Cornea and Refractive Surgery Division at Rutgers New Jersey Medical School and Visiting Research Collaborator at Princeton University. Steven A. Greenstein, M.D. graduated from New York University and received his M.D. from the Albert Einstein College of Medicine where he graduated with a special distinction in clinical research. Dr. Greenstein completed an Internal Medicine Internship, prior to the start of Ophthalmology Residency training at Rutgers New Jersey Medical School. While at Rutgers, Dr. Greenstein trained under Dr. Peter Hersh. He went on to complete a Cornea, Refractive and External Disease Fellowship at Massachusetts Eye and Ear at Harvard Medical School. Additionally he is an Assistant Clinical Professor of the Cornea, Refractive & Anterior Segment Surgery Division of Rutgers New Jersey Medical School. John D. Gelles, O.D., F.I.A.O., F.C.L.S.A., F.S.L.S. is the director of the specialty contact lens division at The CLEI Center for Keratoconus. He graduated from University of Oregon and received his O.D. from the Pennsylvania College of Optometry. He went on to complete a Cornea Fellowship under Dr. Peter Hersh. He is an adjunct clinical professor in Cornea and Contact Lens for New England College of Optometry and State University of New York College of Optometry. David S. Chu, M.D. received his bachelor’s degree from Bowdoin College. He is a graduate of New York University School of Medicine and completed his ophthalmology residency at New York Medical College. Then he completed a fellowship in Ocular Inflammatory Disease and Uveitis at the Massachusetts Eye and Ear infirmary of Harvard Medical School. Additionally, he is an Assistant Professor at the Department of Ophthalmology at the UMDNJ – New Jersey Medical School. Please visit our website for more information or contact us at info@vision-institute.com or 201-371-6221
